Viatris (VTRS) Current Assets (2019 - 2026)
Viatris (VTRS) recorded quarterly Current Assets of $10.9 billion in Q1 2026, up 11.52% quarter-over-quarter from $9.8 billion in Q4 2025, and up 13.45% on a YoY basis from $9.6 billion in Q1 2025.
Viatris (VTRS) Current Assets (2019 - 2026) Analysis & Trends
Viatris' Current Assets history runs 8 years deep, the most recent figure standing at $10.9 billion for Q1 2026.
- In Q1 2026, Current Assets rose 13.45% year-over-year to $10.9 billion; the TTM figure through Mar 2026 stood at $10.9 billion (up 13.45% YoY), while the FY2025 annual figure was $9.8 billion, up 2.82% from the prior year.
- Current Assets was $10.9 billion for Q1 2026 at Viatris, up from $9.8 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $13.0 billion in Q4 2023 to a low of $9.5 billion in Q4 2024.
- Historically, Current Assets has averaged $10.8 billion across 5 years, with a median of $10.6 billion in 2022.
- Biggest YoY gain for Current Assets was 34.2% in 2024; the steepest drop was 26.63% in 2024.
- A 5-year view of Current Assets shows it stood at $10.6 billion in 2022, then rose by 22.01% to $13.0 billion in 2023, then fell by 26.63% to $9.5 billion in 2024, then climbed by 2.82% to $9.8 billion in 2025, then advanced by 11.52% to $10.9 billion in 2026.
- The last three Current Assets figures came in at $10.9 billion (Q1 2026), $9.8 billion (Q4 2025), and $10.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.71 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.47 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.87 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.44 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.58 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.36 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 942.29 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.05 Bn |
| 10 | Viatris | - | - | 1.16 Bn | 10.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.92 Bn |
| Dec 31, 2025 | 9.79 Bn |
| Sep 30, 2025 | 9.95 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Mar 31, 2025 | 9.62 Bn |
| Dec 31, 2024 | 9.52 Bn |
| Sep 30, 2024 | 11.31 Bn |
| Jun 30, 2024 | 11.79 Bn |
| Mar 31, 2024 | 12.92 Bn |
| Dec 31, 2023 | 12.98 Bn |
| Sep 30, 2023 | 10.93 Bn |
| Jun 30, 2023 | 9.78 Bn |
| Mar 31, 2023 | 9.63 Bn |
| Dec 31, 2022 | 10.64 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 11.18 Bn |
| Mar 31, 2022 | 11.74 Bn |
| Dec 31, 2021 | 10.90 Bn |
| Sep 30, 2021 | 11.31 Bn |
| Jun 30, 2021 | 11.75 Bn |